1 / 21

When Using DOPPS Slides

When Using DOPPS Slides. DOPPS Slide Use Guidelines. C-Reactive Protein (CRP) and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Introduction. DOPPS Background (1). DOPPS Background (2). Methods.

tyler
Download Presentation

When Using DOPPS Slides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. C-Reactive Protein (CRP) and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

  4. Introduction

  5. DOPPS Background (1)

  6. DOPPS Background (2)

  7. Methods

  8. Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (1)

  9. Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (2)

  10. Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (3)

  11. Table 2. Baseline Characteristics for Patients by High vs Low Facility Percentage CRP Measurement, all DOPPS Countries Except US and Canada (1)

  12. Table 2. Baseline Demographics for Patients by High vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (2)

  13. Table 2. Baseline Demographics for Patients by High vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (3)

  14. Table 3. Mortality Hazards Ratio (HR) by Facility Percent of Patients with CRP Measurement

  15. Conclusions

  16. Acknowledgements

More Related